Rangappa Rajendra, MD
Medical Oncology · Lansdowne, VANPI 1205843810
Payments from drug & device makers
Across 116 payments — averaging $51.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$2K
- CTI Biopharma Corp.$1K
- Novartis$639
- Gilead$186
- AbbVie$181
- Johnson & Johnson$158
- plus $2K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 12 | $1,803 |
| CTI Biopharma Corp. | 1 | $1,438 |
| Novartis | 24 | $639 |
| Gilead | 7 | $186 |
| AbbVie | 4 | $181 |
| Johnson & Johnson(2 entities) | 6 | $158 |
| Rigel Pharmaceuticals, Inc. | 2 | $144 |
| Intuitive Surgical | 1 | $116 |
| Merck | 5 | $106 |
| Caris MPI, Inc. | 5 | $91 |
| Genentech USA, Inc. | 4 | $90 |
| Pfizer | 4 | $87 |
| GSK | 3 | $84 |
| AstraZeneca(2 entities) | 3 | $81 |
| Myriad Genetic Laboratories, Inc. | 3 | $57 |
| Array Biopharma Inc | 3 | $57 |
| Bristol Myers Squibb | 2 | $53 |
| Beone Medicines USA, Inc. | 2 | $48 |
| Beigene USA, Inc. | 2 | $48 |
| E.r. Squibb & Sons, L.L.C. | 2 | $45 |
| Amgen | 2 | $43 |
| Foundation Medicine, Inc. | 2 | $37 |
| Genmab U.S., Inc. | 1 | $32 |
| Pharmaessentia USA Corporation | 1 | $32 |
| Astellas Pharma US Inc | 1 | $31 |
| Urgo Medical North America, LLC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Stemline Therapeutics Inc. | 1 | $27 |
| Eisai Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Puma Biotechnology, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| Deciphera Pharmaceuticals Inc. | 1 | $22 |
| Myovant Sciences Inc. | 1 | $22 |
| Adaptive Biotechnologies Corporation | 1 | $20 |
| Teleflex LLC | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| Seagen Inc. | 1 | $15 |
| Taiho Oncology, Inc. | 1 | $12 |
How this compares
$5,999 in reported general payments places this provider in the 40th percentile of 95 medical oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Lansdowne
- Pranitha NainiLansdowne$8K
- Alexander SpiraFairfax$69.5M
- Jeanny Aragon-ChingFalls Church$9.4M
- Ryan GentzlerCharlottesville$5.6M
- Robert DreicerCharlottesville$5.4M
- Kathleen HarndenFairfax$4M
- Matthew ReilleyCharlottesville$3.8M
- Patrick DillonCharlottesville$2.6M
- Varinder KaurCharlottesville$2.4M
- Adam CohenFairfax$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.